Bandhan Bank could see an uptrend with a suggested buy point of over Rs 185, aiming for potential gains up to Rs 205. SBI Life Insurance is predicted to reach Rs 1,970, with support at Rs 1,850. Hexaware, Angel One, Arvind, and Glenmark exhibit bullish signals. On the contrary, Lodha Developers may face selling pressure, with a possible target of Rs 835.

Private insurers are heavily leaning towards ULIPs in their product offerings for the fiscal year 2026, despite a growing emphasis on protection plans. The recent GST exemption on life insurance policies has encouraged insurers to strengthen their focus on protection-oriented products.

HDFC Securities analyst Unmesh Sharma favors SBI Life and Power Grid for their strong growth prospects. Meanwhile, consumer stocks such as Asian Paints, Crompton, and Sobha are considered attractive due to a post-valuation correction, according to Sharma.

Analysts endorse SBI Life and Galaxy Surfactants, with the latter's strong focus on niche chemicals, international presence, and its growth prospects aligned with Vision 2030 earning their approval. SBI Life demonstrates a notable 19% year-on-year increase in GWP in the fiscal year 26.

Life insurance stocks experienced a rise on May 11, with SBI Life, ICICI Prudential, and Canara HSBC leading the way. The boost was driven by significant growth in new business premium (NBP), with SBI Life reporting an 80% increase in April FY27. HDFC Life and LIC also demonstrated strong NBP growth of 30% and 38%, respectively.

SBI Life saw a significant increase in its business performance in April, with retail premium earnings jumping 120% year-over-year. LIC followed closely behind, registering a 38% growth in their new business premium and a 19% rise in retail premiums for the same period. Canara HSBC also reported positive gains.

SBI Life Insurance took the lead, driving an impressive 41% increase in new life insurance premiums during April. This indicates growing interest and trust in their services.

Despite the removal of GST, life insurance policies grew only moderately by 4.7% year-on-year in FY26. Contrastingly, new business premiums exhibited a more significant increase of 15.7%, suggesting larger policy amounts rather than just expanded customer base.

SBI Life's premium growth showed improvement in April, according to CEO Amit Jhingran's report.

Life insurance companies experienced a significant 15.7% year-over-year increase in New Business Premium (NBP) during fiscal year 2026. However, the outlook for fiscal year 2027 remains uncertain due to global and regulatory influences, suggesting an uneven growth momentum ahead.

The government is considering opening up banking services for insurance sales through banks, a move that could potentially lead to more partnerships like the one between SBI Life and SBI. This open model offers opportunities for multiple collaborations, not just limiting them to single partnerships.

Investment advisory ICICI Securities suggests purchasing shares in SBI Life Insurance, forecasting a potential price of INR 2,345. They recommend this as a 'buy' opportunity for investors.

SBILife shares experienced a dip, moving away from the high point they reached on Friday.

SBI Life's quality has been downgraded from 'Good' to 'Average', indicating potential concerns in their financial health. Despite retaining its large-cap status, the mixed fundamentals warrant a closer look for investors.

Post Q4 results, various brokerages have adjusted their ratings for L&T Tech, Trent, SBI Life, and Tech Mahindra. The revised ratings reflect strategic shifts, margin concerns, and macroeconomic risks. Notably, Trent and SBI Life remain firmly positioned despite these challenges.

SBI Life's Q4 profit slightly decreased by 1% year-over-year, reaching 804 crores. However, the company managed to boost its net premium income by 16% YoY, totaling 27,684 crores for Q4 FY26.

SBI Life's VNB margin reached 27.5% in the fiscal year 2026, indicating a strong financial health and impressive profitability, as suggested by their revised earnings per share and overall fundamentals. (MarketScreener India)

Despite SBI Life's Q4 Variable New Business (VNB) missing estimates by 4-6%, Jefferies remains optimistic with a 'Buy' rating and a target price of ₹2,550. This is driven by a positive FY27 outlook that includes projected VNB margins of 27-28%, APE growth at 12%, VNB growth at 17%, and minimal regulatory risk.

Nomura continues to recommend purchasing SBI Life Insurance, with a target price of ₹2,440. The recommendation is based on the insurer's strong performance, anticipated 14% annual growth in APE, and robust operating margin. Notably, they praise SBI Life's high return on equity and express that uncertainties regarding open architecture pose little risk to its premium valuation.

SBI Life's share price declined by 3.5% following the release of Q4 results, but major brokerages like Jefferies, Nomura, and HSBC continue to recommend a 'Buy' on the stock. The company anticipates a growth rate of 14% in FY27, with margins projected between 27-28%. The Q4 VNB margin was reported at 28.4%, slightly aligning with estimates.

SBILife shows a significant 3% increase, marking a promising recovery from recent lows. The growth indicates potential stability for the life insurance company.

SBI Life aims for a significant 14% expansion in assets under management, reaching approximately Rs 4.9 trillion, along with a projected 15% increase in individual embedded value (IEV).

ScoutQuest advises investing in SBILife, setting a price target at ₹2,350. This recommendation is based on MOSL's confidence in SBILife's future growth due to its consistent VNB margin and projected 14% APE growth, as well as an anticipated improvement in product mix leading to a margin of 27-28%.

SBI Life projects a moderate shift in their bancassurance distribution towards agency sales and new business, amounting to 3-4%. The company has incorporated GST-related expenses into its overall outlook.

SBI Life Insurance's Q4 profits slightly dipped from last year, coming in at ₹8.05B compared to ₹8.1B in the same period of 2020.

HDFC Securities has provided an analysis of the Q4 FY26 results for SBI Life, Trent, Tech Mahindra, L&T Tech, and Havells. Detailed findings and conclusions are available only through a linked PDF or premium subscription to NDTV Profit.

SBI Life dominates the private life insurance market, capturing a significant 25.5% share of new business premiums. The company's after-tax profits (APE) increased by 13% to reach ₹242.7 billion, while profit after tax (PAT) grew moderately by 2%.

The Sensex and Nifty are predicted to start the day lower due to escalating Iran tensions pushing Brent Crude prices over $102/barrel. Meanwhile, SBI Life's profits have dipped, while Trent records a 26% growth, proposing a bonus issue and fundraising of INR 2500 crores.

Morgan Stanley maintains a positive stance on SBI Life, anticipating a target price of ₹2,375 due to minimal regulatory risks. The robust SBI banking model, low instances of mis-selling, and cost efficiency contribute to a robust outlook for SBI Life.

SBILife is set to reveal their Q4 financial results today, providing insight into the company's performance during the final quarter of 2021. Investors and stakeholders will be keenly watching for any signs of growth or challenges in the market.

SBI Life's upcoming Q4 results suggest a strain on their profitability, with margins anticipated to decrease significantly.

Morgan Stanley anticipates a potential 24% growth in SBI Life's shares due to its low regulatory risk and effective cost management. Despite a predicted 2.9% decrease in Q4 net profit year-on-year, SBI Life's premium income is expected to rise by 12%.

Morgan Stanley maintains a positive stance on SBI Life, setting a target price of INR 2,375 and continuing to recommend it as an investment opportunity.

SBI Life and Canara HSBC experienced significant drops following comments from DFS about exclusive tie-ups, with SBI Life falling to Rs 1915 and Canara HSBC dropping to Rs 143.8, due to concerns over open architecture.

SBI Life reported a significant 26.4% year-on-year increase in their first-year premium for March, reaching INR 48.95 billion, demonstrating strong growth in the insurance sector.

SBI Life executed a significant block trade on the National Stock Exchange (NSE), selling 159,489 shares for approximately $30.41 million or roughly ₹3.04 billion at a price of ₹1907 per share.

Next week, several significant companies like Reliance Industries, Infosys, Axis Bank, Trent, HCL Tech, SBI Life, IndusInd Bank, and IDFC First Bank will release their Q4 results. Stay tuned for updates on these key players in the business sector.

Macquarie recommends HDFC Bank and ICICI Bank as attractive investments, given current margin pressures in India's banking sector. Additionally, they favor HDFC Life and SBI Life over PSU banks, due to challenges such as Q4 treasury losses and tight liquidity faced by the latter.

According to JM Financial's analysis, SBI Life is forecasted to outperform its private life insurance peers by a significant margin of 300-400 basis points. Despite the overall weakening in the life insurance sector due to decreased ULIP demand, SBI Life and Axis Max Life have managed to buck the trend and show growth.

SBI Life's after-tax embedded value (APE) for the fiscal year 2026 grew by 8%, falling short of its projected 14% target, indicating a missed financial goal for the insurance company in the given period.